Free Trial
→ Altucher: Turn $900 into $108,000 in just 12 months? (From Paradigm Press) (Ad) Buy TARS Stock  Free TARS Stock Alerts

Tarsus Pharmaceuticals (TARS) SEC Filings & 10K Form

Tarsus Pharmaceuticals logo
$49.12 +0.40 (+0.82%)
Closing price 04:00 PM Eastern
Extended Trading
$49.04 -0.07 (-0.15%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Tarsus Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
03/26/2025
3:47 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
8:49 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:29 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:30 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:35 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:18 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:21 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:11 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:24 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:27 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:22 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:23 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
8:38 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:26 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:26 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:31 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:20 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:37 PM		Tarsus Pharmaceuticals (Filer)
Form 424B5
03/13/2025
3:40 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:26 PM		Tarsus Pharmaceuticals (Filer)
Form 424B5
03/07/2025
3:17 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
11:22 AM		Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:08 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
01/13/2025
7:30 AM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:03 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:05 PM		Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:06 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:40 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
9:26 AM		Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/05/2024
3:06 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:00 PM		Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/21/2024
3:11 PM		BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2024
4:27 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:52 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:34 PM		LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:21 PM		Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:22 PM		CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:23 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:24 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:25 PM		LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM		Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM		Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:26 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:44 PM		CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:45 PM		Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:33 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:38 PM		Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM		Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:28 PM		LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:30 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:12 PM		Tarsus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:24 PM		Tarsus Pharmaceuticals (Filer)
Form DEF 14A
04/26/2024
3:25 PM		Tarsus Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
7:34 AM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TARS) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored